The Significance of Immunohistochemical Expression of Merlin, Ki-67, and p53 in Meningiomas

被引:17
作者
Pavelin, Sanda [2 ]
Becic, Kristijan [1 ]
Forempoher, Gea [1 ]
Tomic, Snjezana [1 ]
Capkun, Vesna [3 ]
Drmic-Hofman, Irena [1 ]
Mrklic, Ivana [1 ]
Lusic, Ivo [2 ]
Pogorelic, Zenon [4 ]
机构
[1] Univ Split, Sch Med, Dept Pathol Forens Med & Cytol, Split, Croatia
[2] Univ Split, Dept Neurol, Split, Croatia
[3] Univ Split, Dept Nucl Med, Sch Med, Split, Croatia
[4] Univ Split, Dept Pediat Surg, Split Univ Hosp Ctr, Sch Med, Split, Croatia
关键词
meningioma; merlin; Ki-67; p53; TUMOR-SUPPRESSOR; PROTEIN EXPRESSION; NF2; PATHOGENESIS; PROGESTERONE; MIB-1; DAL-1;
D O I
10.1097/PAI.0b013e318289f490
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Meningiomas are one of the most common CNS tumors whose appearance is closely linked to NF2 gene product merlin. Tumor markers Ki-67 and p53 play established role in tumor progression which should be analyzed in close association with merlin expression. The aim of this study was to investigate the immunohistochemical expression of merlin in meningiomas, correlation with Ki-67 and p53, and to determine the association of these results with histologic grade and subtype. The histologic sections of 170 patients with totally resected meningiomas, between January 2000 and December 2010, were classified according to WHO, immunohistochemically stained for Ki-67, p53, and merlin, and analyzed using light microscope. Ki-67 median was 5.6 times higher in group of patients with negative merlin than in those with positive merlin (P=0.05). Statistically significant correlation of merlin with p53 was found (P<0.001). Merlin expression between 2 combined groups (meningothelial/secretory and fibroblastic/transitional) was statistically significant (P=0.002). By comparing merlin expression and p53 levels, statistically significant difference was found (P=0.017). In the group with positive merlin and negative p53 as well as positive merlin and low p53, meningothelial/secretory subtypes of meningiomas were more common. In combination of negative merlin and negative p53 as well as negative merlin and high p53, there were more meningiomas of fibroblastic/transitional subtype. There was no statistically significant correlation between merlin and tumor grade (P=0.420). There is undeniable influence of merlin on the development and the proliferative ability of meningioma subtypes. Significant role of p53 pathway was confirmed.
引用
收藏
页码:46 / 49
页数:4
相关论文
共 25 条
[1]  
Abramovich CM, 1999, ARCH PATHOL LAB MED, V123, P793
[2]   p53 Protein expression in meningiomas - a clinicopathologic study of 55 patients [J].
Aguiar, PH ;
Agner, C ;
Simm, R ;
Freitas, AB ;
Tsanaclis, AMC ;
Plese, JPP .
NEUROSURGICAL REVIEW, 2002, 25 (04) :252-257
[3]   P53 PROTEIN EXPRESSION IN CENTRAL-NERVOUS-SYSTEM NEOPLASMS [J].
BARBARESCHI, M ;
IUZZOLINO, P ;
PENNELLA, A ;
ALLEGRANZA, A ;
ARRIGONI, G ;
PALMA, PD ;
DOGLIONI, C .
JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (07) :583-586
[4]   NF2 gene expression in sporadic meningiomas:: Relation to grades or histotypes real time-PCR study [J].
Buccoliero, Anna M. ;
Castiglione, Francesca ;
Degl'Innocenti, Duccio R. ;
Gheri, Chiara F. ;
Garbini, Francesca ;
Taddei, Antonio ;
Ammannati, Franco ;
Mennonna, Pasquale ;
Taddei, Gian L. .
NEUROPATHOLOGY, 2007, 27 (01) :36-42
[5]   Merlin expression in secretory meningiomas: Evidence of an NF2-independent pathogenesis? - Immunohistochemical study [J].
Buccoliero, Anna Maria ;
Gheri, Chiara Francesca ;
Castiglione, Francesca ;
Ammannati, Franco ;
Gallina, Pasquale ;
Taddei, Antonio ;
Garbini, Francesca ;
Degl'Innocenti, Duccio Rossi ;
Arganini, Luisa ;
Di Lorenzo, Nicola ;
Mennonna, Pasquale ;
Taddei, Gian Luigi .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2007, 15 (03) :353-357
[6]   A role for the p53 pathway in the pathology of meningiomas with NF2 loss [J].
Chang, ZeNan ;
Guo, Chin-Lin ;
Ahronowitz, Iris ;
Stemmer-Rachamimov, Anat O. ;
MacCollin, Mia ;
Nunes, Fabio P. .
JOURNAL OF NEURO-ONCOLOGY, 2009, 91 (03) :265-270
[7]   Role of p53 gene mutation in tumor aggressiveness of intracranial meningiomas [J].
Cho, H ;
Ha, SY ;
Park, SH ;
Park, K ;
Chae, YS .
JOURNAL OF KOREAN MEDICAL SCIENCE, 1999, 14 (02) :199-205
[8]   The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments [J].
Choy, Winward ;
Kim, Won ;
Nagasawa, Daniel ;
Stramotas, Stephanie ;
Yew, Andrew ;
Gopen, Quinton ;
Parsa, Andrew T. ;
Yang, Isaac .
NEUROSURGICAL FOCUS, 2011, 30 (05)
[9]  
Commins Deborah L, 2007, Neurosurg Focus, V23, pE3
[10]   Epidemiology of primary intracranial tumours in NW Italy, a population based study: stable incidence in the last two decades [J].
Cordera, S ;
Bottacchi, E ;
D'Alessandro, G ;
Machado, D ;
De Gonda, F ;
Corso, G .
JOURNAL OF NEUROLOGY, 2002, 249 (03) :281-284